feed,title,long_url,short_url
Benzinga,Regeneron's Q4 Double-Digit Top and Bottom-Line Growth Propelled By Higher Sales From Eylea And Dupixent,https://www.benzinga.com/general/biotech/21/02/19509102/regenerons-q4-double-digit-top-and-bottom-line-growth-propelled-by-higher-sales-from-eylea-and-du,https://j.mp/3pREqhZ
